Guosen Ye

Person

  • King of Prussia, PA, US

Patents Grantslast 30 patents

  • Information Patent Grant

    MrgX2 antagonists

    • Patent number 11,976,057
    • Issue date May 7, 2024
    • GlaxoSmithKline Intellectual Property Development Limited
    • Edward Brnardic
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Heterocyclic amides useful as protein modulators

    • Patent number 11,970,480
    • Issue date Apr 30, 2024
    • GlaxoSmithKline Intellectual Property Development Limited
    • Adam Kenneth Charnley
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    TRPV4 antagonists

    • Patent number 11,229,623
    • Issue date Jan 25, 2022
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Edward J. Brnardic
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    TRPV4 antagonist

    • Patent number 10,968,209
    • Issue date Apr 6, 2021
    • GlaxoSmithKline Intellectual Property (No. 2) Limited
    • Patrick Stoy
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    TRPV4 antagonists

    • Patent number 10,588,891
    • Issue date Mar 17, 2020
    • GlaxoSmithKline Intellectual Property Development Limited
    • Edward J. Brnardic
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Hydroxy formamide derivatives and their use

    • Patent number 10,450,288
    • Issue date Oct 22, 2019
    • GlaxoSmithKline Intellectual Property (No. 2) Limited
    • Sarah E. Dowdell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    TRPV4 antagonists

    • Patent number 9,487,507
    • Issue date Nov 8, 2016
    • GlaxoSmithKline Intellectual Property (No. 2) Limited
    • Carl Brooks
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    TRPV4 antagonists

    • Patent number 9,187,464
    • Issue date Nov 17, 2015
    • GlaxoSmithKline Intellectual Property (No. 2) Limited
    • Carl Brooks
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    TRPV4 antagonists

    • Patent number 8,658,636
    • Issue date Feb 25, 2014
    • GlaxoSmithKline, LLC
    • Carl A. Brooks
    • C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

  • Information Patent Application

    CYTOTOXICITY TARGETING CHIMERAS FOR CCR2-EXPRESSING CELLS

    • Publication number 20250057958
    • Publication date Feb 20, 2025
    • GlaxoSmithKline Intellectual Property Development Limited
    • Peiling Chen
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    CYTOTOXICITY TARGETING CHIMERAS FOR CCR2-EXPRESSING CELLS

    • Publication number 20240325392
    • Publication date Oct 3, 2024
    • GlaxoSmithKline Intellectual Property Development Limited
    • Peiling CHEN
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    Heterocyclic Amides Useful as Protein Modulators

    • Publication number 20230071675
    • Publication date Mar 9, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Adam Kenneth CHARNLEY
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MRGX2 ANTAGONISTS

    • Publication number 20220112174
    • Publication date Apr 14, 2022
    • GlaxoSmithKline Intellectual Property Development Limited
    • Edward BRNARDIC
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    HETEROCYCLIC AMIDES USEFUL AS PROTEIN MODULATORS AND METHODS OF USI...

    • Publication number 20210238172
    • Publication date Aug 5, 2021
    • GlaxoSmithKline Intellectual Property Development Limited
    • Adam Kenneth CHARNLEY
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    TRPV4 ANTAGONIST

    • Publication number 20200308160
    • Publication date Oct 1, 2020
    • GlaxoSmithKline Intellectual Property (No.2) Limited
    • Patrick STOY
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    TRPV4 ANTAGONISTS

    • Publication number 20200261411
    • Publication date Aug 20, 2020
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Edward J. BRNARDIC
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    HYDROXY FORMAMIDE DERIVATIVES AND THEIR USE

    • Publication number 20200095217
    • Publication date Mar 26, 2020
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Sarah E. DOWDELL
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    TRPV4 ANTAGONISTS

    • Publication number 20190216774
    • Publication date Jul 18, 2019
    • GlaxoSmithKline Intellectual Property (No.2) Limited
    • Edward J. BRNARDIC
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    HYDROXY FORMAMIDE DERIVATIVES AND THEIR USE

    • Publication number 20160340328
    • Publication date Nov 24, 2016
    • Sarah E. DOWDELL
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    TRPV4 ANTAGONISTS

    • Publication number 20140121206
    • Publication date May 1, 2014
    • GlaxoSmithKliine, LLC
    • Carl Brooks
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    TRPV4 ANTAGONISTS

    • Publication number 20140113916
    • Publication date Apr 24, 2014
    • GlaxoSmithKline, LLC
    • Carl Brooks
    • C07 - ORGANIC CHEMISTRY